Gel-trapped lymphorganogenic chemokines trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo

Frontiers in Immunology

Volumn 7, Issue AUG, 2016, Pages

  Kobayashi, Yuka ^a   Watanabe, Takeshi ^a  

^a Kitano Hospital   (Japan)

Author keywords

Artificial tertiary lymphoid organs; Immune therapeutics; Primary immune deficiencies

Indexed keywords

CHEMOKINE; COLLAGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LYMPHOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL AGGREGATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GEL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOHISTOCHEMISTRY; LYMPHOID ORGAN; LYMPHOID TISSUE; MEMORY CELL; MOUSE; NONHUMAN; ORGANOGENESIS; T LYMPHOCYTE; TISSUE GRAFT;

EID: 84990051267     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00316     Document Type: Article

References (80)

1. Dieu-Nosjean MC, Goc J, Giraldo NA, Friedman CS, Friedman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol (2014) 35:571-80. doi: 10.1016/j.it.2014.09.006
2. Chen L, Fabian KL, Taylor JL, Storkus WL. Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity. Front Immunol (2013) 4:388. doi:10.3389/fimm.2013.00388
3. Tang H, Wang Y, Chlewicki LK, Zhang Y, Guo J, Liang W, et al. Facilitating T cell infiltration in tumor microenvironement overcomes resistance to PD-L1 blockade. Cancer Cell (2016) 29:285-96. doi:10.1016/j.ccell.2016.02.004
4. Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med (2003) 197(9):1153-63. doi:10.1084/jem.20021761
5. Wang J, Foster A, Chin R, Yu P, Sun Y, Wang Y, et al. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol (2002) 32:1969-79. doi:10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M
6. Gommerman JL, Browning JL. Lymphotoxin/LIGHT, lymphoid microenvironments and disease. Nat Rev Immunol (2003) 3:642-55. doi:10.1038/nri1151
7. Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxinbeta in mesenteric lymph node genesis. J Exp Med (2002) 195:1613-24. doi:10.1084/jem.20020215
8. Leslie M. Features: immunity goes local. Science (2016) 352:21-3. doi:10.1126/science.352.6281.21
9. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 20:26-42. doi:10.1016/j.smin.2007.12.004
10. Roozendaal R, Mebius RE. Stromal cell-immune cell interactions. Annu Rev Immunol (2011) 29:23-43. doi:10.1146/annurev-immunol-031210-101357
11. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol (2006) 7(4):344-53. doi:10.1038/ni1330
12. Thaunat O, Field AC, Dai J, Louedec L, Patey N, Bloch MF, et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A (2005) 102(41):14723-8. doi:10.1073/pnas.0507223102
13. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell (2012) 150(1):194-206. doi:10.1016/j.cell.2012.05.032
14. Fletcher AL, Malhotra D, Acton SE, Lukacs-Kornek V, Bellemare-Pelletier A, Curry M, et al. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front Immunol (2011) 2:35. doi:10.3389/fimmu.2011.00035
15. Chai Q, Onder L, Scandella E, Gil-Cruz C, Perez-Shibayama C, Cupovic J, et al. Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity (2013) 38(5):1013-24. doi:10.1016/j.immuni.2013.03.012
16. Kraz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med (1996) 183:1461-72. doi:10.1084/jem.183.4.1461
17. Martin AP, Coronal EC, Sano G, Chen SC, Vassiliva G, Canasto-Chibuque C, et al. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC Chemokine CCL21. J Immunol (2004) 173:4791-8. doi:10.4049/jimmunol.173.8.4791
18. Furtado GC, Marinkovic T, Martin AP, Garin A, Hoch B, Hubner W, et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci USA (2007) 104:5026-31. doi:10.1073/pnas.0606697104
19. Zeng M, Paiardini M, Engram JC, Beilman GJ, Chipman JG, Schacker TW, et al. Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood (2012) 120(9):1856-67. doi:10.1182/blood-2012-03-418624
20. Sato-Hashimoto M, Saito Y, Ohnishi H, Iwamura H, Kanazawa Y, Kaneko T, et al. Signal regulator protein alpha regulates the homeostasis of T lymphocytes in the spleen. J Immunol (2011) 187:291-7. doi:10.4049/jimmunol.1100528
21. Pikor NB, Astarita JL, Summers-Deluca L, Galicia G, Qu J, Ward LA, et al. Integration of Th17-and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity (2015) 43(6):1160-73. doi:10.1016/j.immuni.2015.11.010
22. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol (2002) 169(1):424-33. doi:10.4049/jimmunol.169.1.424
23. Manzo A, Bugatti S, Caporali R, Prevo R, Jackson DG, Uguccioni M, et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol (2007) 171(5):1549-62. doi:10.2353/ajpath.2007.061275
24. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science (2010) 328(5979):749-52. doi:10.1126/science.1185837
25. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P, et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol (2009) 10(11):1193-9. doi:10.1038/ni.1789
26. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med (2000) 192(11):1553-62. doi:10.1084/jem.192.11.1553
27. Schmitt N, Bentebibel SE, Ueno H. Phenotype and functions of memory Tfh cells in human blood. Trends Immunol (2014) 35(9):436-42. doi:10.1016/j.it.2014.06.002
28. Aguzzi A, Kranich J, Krautier NJ. Follicular dendritic cells: origin, phenotype, and function in health ans disease. Trends Immunol (2014) 35:105-13. doi:10.1016/j.it.2013.11.001
29. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature (2000) 406(6793):309-14. doi:10.1038/35018581
30. Dubey LK, Lebbon L, Mosconi I, Yang CY, Scandella E, Ludewig B, et al. Lymphotoxin-dependent B cell-FRC crosstalk promotes de novo follicle formation and antibody production following intestinal helminth infection. Cell Rep (2016) 15:1-15. doi:10.1016/j.celrep.2016.04.020
31. Cremasco V, Woodruff MC, Onder L, Cupovic J, Nieves-Bonilla JM, Schildberg FA, et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol (2014) 15(10):973-81. doi:10.1038/ni.2965
32. Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol (2008) 181(6):3887-96. doi:10.4049/jimmunol.181.6.3887
33. Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, Forster R, et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med (2008) 205(11):2483-90. doi:10.1084/jem.20080039
34. Molenaar R, Greuter M, van der Marel AP, Roozendaal R, Martin SF, Edele F, et al. Lymph node stromal cells support dendritic cell-induced gut-homing of T cells. J Immunol (2009) 183(10):6395-402. doi:10.4049/jimmunol.0900311
35. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med (2004) 200(6):783-95. doi:10.1084/jem.20040254
36. Tomei AA, Siegert S, Britschgi MR, Luther SA, Swartz MA. Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J Immunol (2009) 183(7):4273-83. doi:10.4049/jimmunol.0900835
37. Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/-mice. J Exp Med (2009) 206(1):233-48. doi:10.1084/jem.20080752
38. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity (2004) 21(4):527-38. doi:10.1016/j.immuni.2004.08.011
39. Lotzer K, Dopping S, Connert S, Grabner R, Spanbroek R, Lemser B, et al. Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler Thromb Vasc Biol (2010) 30(3):395-402. doi:10.1161/atvbaha.109.191395
40. Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity (2015) 42(6):1100-15. doi:10.1016/j.immuni.2015.05.015
41. Peduto L, Dulauroy S, Lochner M, Spath GF, Morales MA, Cumano A, et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol (2009) 182(9):5789-99. doi:10.4049/jimmunol.0803974
42. Nasr IW, Reel M, Oberbarnscheidt MH, Mounzer RH, Baddoura FK, Ruddle NH, et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant (2007) 7(5):1071-9. doi:10.1111/j.1600-6143.2007.01756.x
43. Randall TD, Carragher DM, Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol (2008) 26:627-50. doi:10.1146/annurev.immunol.26.021607.090257
44. Thaunat O, Graff-Dubois S, Brouard S, Gautreau C, Varthaman A, Fabien N, et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS One (2010) 30:e11398. doi:10.1371/journal.pone.0011398
45. Sicard A, Chen CC, Morelon E, Thaunat O. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection. Curr Opin Organ Transplant (2016) 21:368-73. doi:10.1097/MOT.0000000000000329
46. Cupedo T, Stroock A, Coles M. Application of tissue engineering to the immune system: development of artificial lymph nodes. Front Immunol (2012) 3:343. doi:10.3389/fimmu.2012.00343
47. Fletcher AL, Lukacs-Kornek V, Reynoso ED, Pinner SE, Bellemare-Pelletier A, Curry MS, et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med (2010) 207(4):689-97. doi:10.1084/jem.20092642
48. Cohen JN, Guidi CJ, Tewalt EF, Qiao H, Rouhani SJ, Ruddell A, et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via aire-independent direct antigen presentation. J Exp Med (2010) 207(4):681-8. doi:10.1084/jem.20092465
49. Suematsu S, Watanabe T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol (2004) 22(12):1539-45. doi:10.1038/nbt1039
50. Okamoto N, Chihara R, Shimizu C, Nishimoto S, Watanabe T. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest (2007) 117(4):997-1007. doi:10.1172/jci30379
51. Kobayashi Y, Kato K, Watanabe T. Synthesis of functional artificial lymphoid tissues. Discov Med (2011) 12(65):351-62.
52. Kobayashi Y, Watanabe T. Synthesis of artificial lymphoid tissue with immunological function. Trends Immunol (2010) 31(11):422-8. doi:10.1016/j.it.2010.09.002
53. Nakashima M, Mori K, Maeda K, Kishi H, Hirata K, Kawabuchi M, et al. Selective elimination of double-positive immature thymocytes by a thymic epithelial cell line. Eur J Immunol (1990) 20(1):47-53. doi:10.1002/eji.1830200108
54. Young CL, Adamson TC III, Vaughan JH, Fox RI. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum (1984) 27(1):32-9. doi:10.1002/art.1780270106
55. Kobayashi S, Murata K, Shibuya H, Morita M, Ishikawa M, Furu M, et al. A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. Arthritis Rheum (2013) 65(12):3063-72. doi:10.1002/art.38173
56. Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum (2003) 48(11):3187-201. doi:10.1002/art.11311
57. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J Clin Invest (1998) 102(5):938-46. doi:10.1172/jci3234
58. Kielczewski JL, Horai R, Jittayasothorn Y, Chan CC, Caspi RR. Tertiary lymphoid tissue forms in retinas of mice with spontaneous autoimmune uveitis and has consequences on visual function. J Immunol (2016) 196(3):1013-25. doi:10.4049/jimmunol.1501570
59. Sura R, Colombel JF, Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the granuloma of Crohn's disease: an immunohistochemical study. Aliment Pharmacol Ther (2011) 33:930-9. doi:10.1111/j.1365-2036.2011.04605x
60. McNamee EN, Masterson C, Jedlicka P, Collins CB, William IR, Rivera-Nieves J. Ectopic lymphoid tissue alters the chemokine gradient, inctreases lymphoid lymphocyte retention and exacerbates murine ileitis. Gut (2016) 62:53-62. doi:10.1136/gutjnl-2011-301272
61. Aloisi F, Columba-Cabezas S, Franciotta D, Rosicarelli B, Magliozzi R, Reynolds R, et al. Lymphoid chemokines in chronic neuroinflammation. J Neuroimmunol (2008) 198:106-12. doi:10.1016/j.jneuroim.2008.04.025
62. Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddie NH, et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol (2012) 124:861-73. doi:10.1007/s00401-012-1023-3
63. Thompson ED, Enriquez HL, Fu YX, Engelhard VH. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med (2010) 207(8):1791-804. doi:10.1084/jem.20092454
64. Littman DR. Releasing the brakes on cancer immunotherapy. Cell (2015) 162(6):1186-90. doi:10.1016/j.cell.2015.08.038
65. Sharma P, Allison JP. The future of immune checkpoint therapy. Science (2015) 348(6230):56-61. doi:10.1126/science.aaa8172
66. Pan WR, Suami H, Taylor GI. Senile changes in human lymph nodes. Lymphat Res Biol (2008) 6(2):77-83. doi:10.1089/lrb.2007.1023
67. Hadamitzky C, Spohr H, Debertin AS, Guddat S, Tsokos M, Pabst R. Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance? J Anat (2010) 216(5):556-62. doi:10.1111/j.1469-7580.2010.01213.x
68. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol (2005) 23(1):47-55. doi:10.1038/nbt1055
69. Aberle T, Franke K, Rist E, Benz K, Schlosshauer B. Cell-type specific four-component hydrogel. PLoS One (2014) 9(1):e86740. doi:10.1371/journal.pone.0086740
70. Stachowiak AN, Irvine DJ. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. J Biomed Mater Res A (2008) 85(3):815-28. doi:10.1002/jbm.a.31661
71. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol (2001) 19(11):1029-34. doi:10.1038/nbt1101-1029
72. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood (2005) 106(5):1565-73. doi:10.1182/blood-2005-02-0516
73. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood (2002) 100(9):3175-82. doi:10.1182/blood-2001-12-0207
74. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγ(null) humanized mice. Proc Natl Acad Sci U S A (2010) 107(29):13022-7. doi:10.1073/pnas.1000475107
75. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol (2012) 12(11):786-98. doi:10.1038/nri3311
76. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science (2004) 304(5667):104-7. doi:10.1126/science.1093933
77. Danner R, Chaudhari SN, Rosenberger J, Surls J, Richie TL, Brumeanu TD, et al. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One (2011) 6(5):e19826. doi:10.1371/journal.pone.0019826
78. Jaiswal S, Smith K, Ramirez A, Woda M, Pazoles P, Shultz LD, et al. Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice. Exp Biol Med (Maywood) (2015) 240(1):67-78. doi:10.1177/1535370214546273
79. Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol (2010) 28(3):275-80. doi:10.1038/nbt.1607
80. Zhang L, Kovalev GI, Su L. HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood (2007) 109(7):2978-81. doi:10.1182/blood-2006-07-033159